AcrySof phakic angle-supported IOL was implanted in 190 eyes (190 subjects) with moderate to high myopia in this phase three, nonrandomized, open-label, prospective study. One-year postoperative UCVA was 20/20 or better in 57.8 percent of subjects and 20/40 or better in 99.4 percent. All subjects obtained BSCVA of 20/32 or better, and 85.7 percent reached 20/20 or better. Mean central endothelial density decreased 4.77 percent (15 percent experienced 10 percent or more loss). No pupil ovalization, pupillary block or retinal detachment occurred. Ophthalmology, July 2009

Dr Sarbjit Singh
EYE FOR EXCELLENCE

AsianOphthalmology